Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model-Reference-Cited by-同舟云学术

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

Published:2019-04-10 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Liu Wen-Chun,Nachbagauer Raffael,Stadlbauer Daniel,Solórzano Alicia,Berlanda-Scorza Francesco,García-Sastre Adolfo,Palese Peter,Krammer Florian,Albrecht Randy A.

Funder

Bill and Melinda Gates Foundation

National Institute of Allergy and Infectious Diseases

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. Update: Influenza activity in the united states during the 2017-18 season and composition of the 2018-19 influenza vaccine;Garten;MMWR.,2018

2. The future of influenza vaccines: a historical and clinical perspective;Bouvier;Vaccines.,2018

3. The pathway to a universal influenza vaccine;Paules;Immunity.,2017

4. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis;Tricco;BMC Med.,2013

5. The annual production cycle for influenza vaccine;Gerdil;Vaccine.,2003

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the cross‐protection of the Vero cell‐derived attenuated influenza vaccines with compound adjuvant, through intranasal immunization;APMIS;2024-07-03

2. Research Progress on Universal Vaccine Design of Influenza Virus Hemagglutinin Epitopes;Advances in Clinical Medicine;2024

3. A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage;Emerging Microbes & Infections;2023-12-30

4. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses;Journal of Virology;2023-11-30

5. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo;Proceedings of the National Academy of Sciences;2023-10-23